References
- Edwards R. J., Murray B. P., Boobis A. R., Davies D. S. Identification and location of α-helices in mammalian cytochrome P450. Biochemistry 1989; 28: 3762–3770
- Edwards R. J., Singleton A. M., Murray B. P., Sesardic D., Rich K. J., Davies D. S., Boobis A. R. An anti-peptide antibody targeted to a specific region of rat cytochrome P-450IA2 inhibits enzyme activity. Biochemical Journal 1990; 266: 497–504
- Fujita S., Umeda S., Funae Y., Imaoka S., Abe H., Ishida R., Adachi T., Masuda M., Kazusaka A., Suzuki T. Regio- and stereoselective propranolol metabolism by 15 forms of purified cytochrome P-450 from rat liver. Journal of Pharmacology and Experimental Therapeutics 1993; 264: 226–233
- Funae Y., Imaoka S. Simultaneous purification of multiple forms of rat liver microsomal cytochrome P-450 by high-performance liquid chromatography. Biochimica et Biophysica Acta 1985; 842: 119–132
- Gonzalez F. J. The molecular biology of cytochrome P-450s. Pharmacological Review 1989; 40: 243–288
- Gonzalez F. J., Skoda R. C., Kimura S., Umeno M., Zanger U. M., Nebert D. W., Gelboin H. V., Hardwick J. P., Meyer U. A. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 1988; 331: 442–446
- Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
- Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1970; 193: 680–685
- Manns M. P. Autoantibodies and antigens in liver diseases-updated. Journal of Hepatology 1989; 9: 272–280
- Manns M. P., Griffin K. J., Sullivan K. F., Johnson E. F. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. Journal of Clinical Investigation 1991; 88: 1370–1378
- Matsunaga E., Zanger U. M., Hardwick J. P., Gelboin H. V., Meyer U. A., Gonzalez F. J. The CYP2D gene subfamily: analysis of the molecular basis of the debrisoquine 4-hydroxylase deficiency in DA rats. Biochemistry 1989; 28: 7349–7355
- Matsunaga E., Umeno M., Gonzalez F. J. The rat P-450 II D subfamily: complete sequences of four closely linked genes and evidence that gene conversions maintained sequence homogeneity at the heme-binding region of the cythochrome P450 active site. Journal of Molecular Evolution 1990; 30: 155–169
- Nakamura A., Yamamoto Y., Tasaki T., Sugimoto C., Masuda M., Kazusaka A., Fujita S. Purification and characterization of a dog hepatic cytochrome P-450 isozyme belonging to CYP2D subfamily and development of its anti-peptide antibody. Drug Metabolism and Disposition 1995, submitted
- Omura T., Sato R. The carbon monooxide-binding pigment of liver microsomes. Journal of Biological Chemistry 1964; 239: 2370–2378
- Shimada T., Yamazaki H., Mimura M., Inui Y., Guengrich F. P. Interindividual variations in human liver cytochrome P-450 enzyme involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics 1994; 270: 414–423
- Suzuki T., Narimatu S., Fujita S., Masubuchi Y., Umeda S., Imaoka S., Funae Y. Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats. Drug Metabolism and Disposition 1992; 20: 367–373
- Zanger U. M., Hauri H. P., Loeper J., Homberg J. C., Meyer U. A. Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II. Proceedings of the National Academy of Sciences, USA 1988; 85: 8256–8260